We are live on ! Find out more
TGI

TRV GP IV Portfolio holdings

AUM $267M
1-Year Est. Return 965.83%
This Fund
S&P 500
This Quarter Est. Return
-12.54%
1 Year Est. Return
+965.83%
3 Year Est. Return
+686.22%
5 Year Est. Return
+581.56%
10 Year Est. Return
–
AUM
$140M
AUM Growth
-$95.3M
Cap. Flow
-$36.5M
Cap. Flow %
-26.08%
Top 10 Hldgs %
100%
Holding
5
New
–
Increased
–
Reduced
–
Closed
2

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$33.8M
2
DNTH icon
Dianthus Therapeutics
DNTH
+$2.67M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TNGX icon
1
Tango Therapeutics
TNGX
$4.43B
$76.5M 54.67%
19,363,975
– –
PLRX icon
2
Pliant Therapeutics
PLRX
$64.4M
$56.7M 40.55%
2,132,867
– –
FULC icon
3
Fulcrum Therapeutics
FULC
$273M
$6.68M 4.77%
2,343,154
– –
DNTH icon
4
Dianthus Therapeutics
DNTH
$5.84B
– –
-422,388
Closed -$2.67M
RVMD icon
5
Revolution Medicines
RVMD
$39.9B
– –
-1,419,900
Closed -$33.8M

Similar funds

OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
WAM
Weinberger Asset Management Los Angeles, California $267M AUM 19.83% 1-Year Est. Return
IP
Indigo Partners Phoenix, Arizona $267M AUM 9% 1-Year Est. Return
SIA
SGL Investment Advisors Missoula, Montana $266M AUM 18.29% 1-Year Est. Return
CFG
Cambridge Financial Group Columbus, Ohio $267M AUM 31.62% 1-Year Est. Return
EU
Emory University Atlanta, Georgia $267M AUM 48.26% 1-Year Est. Return
PC
Packer & Co Cottesloe, Australia $267M AUM
ALC
Alexander Labrunerie & Co Columbia, Missouri $267M AUM 21.24% 1-Year Est. Return

TRV GP IV's Q1 2023 Portfolio in Review

As of Q1 2023, TRV GP IV held 5 positions worth $140M, down 41% from $235M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

TRV GP IV withdrew a net $36.5M in Q1 2023, closing 2 positions. Its most notable exit was Revolution Medicines, an estimated $33.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • TRV GP IV fully exited Revolution Medicines in Q1 2023, selling an estimated $33.8M.
  • TRV GP IV's ten largest holdings make up 100% of its $140M portfolio in Q1 2023.
  • TRV GP IV opened 0 new positions and closed 2 in Q1 2023.
  • TRV GP IV's portfolio value fell 41% quarter-over-quarter to $140M.

Based on TRV GP IV's 13F filing for Q1 2023, filed 12 May 2023.